JDRF 2020 Gala Ball Announcement
As an organisation, JDRF always has the health and wellbeing of its community at its core. Due to the ongoing spread of COVID-19, our concerns for community health and in line with the government’s directive on such events, we have made the difficult decision to cancel our 2020 Gala Ball events.
A significant amount of work has gone into the organisation of these events to date, and we thank volunteers, suppliers and staff for their support and understanding. However, we feel this is an appropriate response to a challenging situation. We are in the process of contacting individual ticket holders and sponsors to discuss next steps. If you have any pressing concerns, please contact your local JDRF office.
While the COVID-19 pandemic is a serious concern for us all at present, our enduring focus on tackling the challenges of T1D as a chronic, lifelong condition remains. To keep up this work, particularly at such a challenging time, we need your help, now, more than ever. There will be elements of the gala that we will be able to recreate without a physical gathering and will let you know when these are ready to go live. One in every four dollars we fundraise for research locally comes from our Galas, and we need your assistance in ensuring we can continue our momentum on finding new ways to treat, prevent and one day cure type one diabetes.
We thank you for your ongoing support and know we can count on you to continue partnering with us to help create a world without type one diabetes.
If you have any questions regarding this announcement, you can email us at firstname.lastname@example.org.
Report: Aussie adults with type 1 diabetes unable to access life-changing technology due to high cost
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]
T1D Research Roundup: March 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Monash University researchers crack the […]
COVID-19 Vaccines and T1D: Answering Your Questions
Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines beginning to be offered to people with T1D, we’ve gathered all the information you need to […]
Top 10 T1D Research Breakthroughs of 2020
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission to cure, treat and prevent T1D – including new insights into what causes the disease, some incredible results from prevention therapies, and the launch of […]